Clinical trial Recruiting at 8 sites Observational

Understanding Hereditary Spastic Paraplegias and Related Disorders

Official title: Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders

Run by University Hospital Tuebingen · NCT03981276 · Data updated 2026-11-12

This study is trying to learn more about Hereditary Spastic Paraplegias and related disorders by following patients over time and looking at their symptoms, genetics, and potential treatments.

Quick facts

Study typeObservational
SexAll
Enrollment2000 (estimated)
SponsorUniversity Hospital Tuebingen
Academic / other
Locations13 sites (Innsbruck and 12 other locations)
StatusRecruiting
StartedOctober 14, 2019
Main results expectedAugust 2039
Study endsAugust 2041
Registry record updatedMay 19, 2021
Trial IDNCT03981276 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with a clinical or genetic diagnosis of HSP or related disorders, as well as unaffected family members or healthy controls.

Probably not a fit

Patients with evidence of other neurodegenerative diseases or movement disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the clinical spectrum and natural progression of Hereditary Spastic Paraplegias (HSP) and related disorders through a multicenter natural history approach. Participants will undergo annual standardized clinical examinations and have the option to donate biosamples for biomarker analysis. The study will also investigate genetic etiology and molecular mechanisms, utilizing next-generation sequencing for those without a genetic diagnosis. Data will be collected in a clinical database to aid in diagnosis and therapy development.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnosis and treatment options for patients with Hereditary Spastic Paraplegia.

How similar studies have gone: Other studies focusing on the natural history and biomarkers of neurodegenerative diseases have shown promise, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* One of the following:

  1. Primary participant: Clinical or genetic diagnosis of HSP or a related disorder
  2. Secondary participant: Unaffected family member (1st or 2nd degree relative) of primary participant (with the above-mentioned restrictions for special populations) able to give informed consent
  3. Unrelated healthy control able to give informed consent

     AND
* Written informed consent

AND

\- Participants are willing and able to comply with study procedures

Exclusion criteria:

* Missing informed consent of primary or secondary participant/ healthy control/ legal representatives
* For controls: evidence of a neurodegenerative disease or movement disorders; inability to give informed consent

Where it's running

  • University Innsbruck
    Innsbruck, Austria
    Recruiting
  • German Center for Neurodegenerative Diseases (DZNE) Bonn
    Bonn, Germany
    Recruiting
  • University of Erlangen
    Erlangen, Germany
    Recruiting
  • University Medicine Essen
    Essen, Germany
    Recruiting
  • University Göttingen
    Göttingen, Germany
    Recruiting
  • German Center for Neurogedenerative Diseases (DZNE) Magdeburg
    Magdeburg, Germany
    Recruiting
Show 7 more locations
  • German Center for Neurodegenerative Diseases (DZNE) München
    München, Germany
    Recruiting
  • University of Tübingen and German Center for Neurodegenerative Diseases (DZNE) Tübingen
    Tübingen, Germany
    Recruiting
  • University Heidelberg
    Heidelberg, Germany
    Not yet recruiting
  • University of Lübeck
    Lübeck, Germany
    Not yet recruiting
  • University of Regensburg
    Regensburg, Germany
    Not yet recruiting
  • German Center for Neurodegenerative Diseases (DZNE) Rostock
    Rostock, Germany
    Not yet recruiting
  • IRCCS Medea Scientific Institute, Conegliano-PIeve di Soligo Research Centre
    Pieve di Soligo, Italy
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.